Disclosures

Intimation - Calquence_Additional Indication

PDF 3,274KB

Intimation - Analyst - Investor Meeting

PDF 250KB

Intimation – Resignation of Sylvia Varela

PDF 344KB

Appointment of Company Secretary

PDF 251KB

Intimation - Imfinzi-Additional Indication

PDF 303KB

Intimation - Calquence ECHO - Additional Indication

PDF 3,275KB

Intimation - Resignation of Senior Management Personnel

PDF 399KB

Intimation – Update on Senior Management Personnel

PDF 3,291KB

Intimation - AY-2022-23-Final Order

PDF 336KB

Intimation - ESG Rating - SES

PDF 253KB

Intimation – ESG Rating - NSE Sustainability

PDF 248KB

Intimation - Resignation of Non-Executive Director

PDF 455KB

Press Release Q4 2025-26

PDF 334KB

Intimation - Surrender of factory license

PDF 289KB

Intimation – Imfinzi MATTERHORN_Additional Indication

PDF 247KB

Intimation - Aditi Mehta and Nitin Bindal

PDF 251KB

Intimation - Imfinzi DUO-E_Additional Indication

PDF 246KB

Appointment of Sandhya Tejaswini Amanna

PDF 309KB

Intimation – Amendment of Memorandum of Association

PDF 3,471KB

Outcome of Board Meeting May 26, 2026

PDF 1,047KB

Intimation - Tax Litigation FY 2018-19

PDF 299KB

Intimation - Appointment of Director Corporate Affairs

PDF 293KB

Appointment of Amay, Mihir and Change in designation of Vinay

PDF 313KB

Intimation - Resignation of Bhavana as Chief Financial Officer

PDF 501KB

Intimation - Enhertu DB11 - Marketing Authorisation

PDF 286KB

Intimation - Enhertu DB09 - Marketing Authorisation

PDF 285KB

Intimation - Fasenra HES Additional Indication

PDF 285KB

Intimation -Newspaper Publication for AGM 2026

PDF 3,240KB

Intimation - NPPA Demand Notice

PDF 301KB

Intimation - Resignation of Aditi Mehta and Srikanth B.S.

PDF 597KB

Record date for payment of dividend

PDF 242KB

Communication to Shareholders w.r.t. TDS on Dividend

PDF 510KB

Intimation - Symbicort Demand Notice

PDF 300KB

Intimation - Imfinzi Adriatic

PDF 240KB

Intimation - AY 2022 - 23_Order

PDF 514KB

Intimation - Discontinuation of Imdur

PDF 499KB

Soliris Marketing Authorisation

PDF 240KB

Intimation - AY 2014-15_Order

PDF 513KB

Intimation AY 2022-23 TPO Order

PDF 303KB

Intimation for BBMP Litigation

PDF 273KB

Intimation on BSE warning letter

PDF 458KB

Press Release Q3 2024-25

PDF 549KB

Intimation on NSE warning letter

PDF 379KB

Appointment of Dr. Sandeep Arora as Director Medical Affairs

PDF 500KB

Intimation Imfinzi Himalaya - MA

PDF 496KB

Appointment of Harish Dash - IT Head

PDF 502KB

Intimation MA Lokelma

PDF 240KB

Appointment of Secretarial Auditor

PDF 271KB

Declaration of Dividend 2024-25

PDF 397KB

Intimation - Tagrisso_Marketing Authorisation

PDF 246KB

Intimation for Investor meet

PDF 508KB

Intimation_Enhertu-HER2 low_Marketing Authorisation

PDF 346KB

Intimation_Lynparza-Propel_Withdrawal of Indication

PDF 494KB

Intimation-Fasenra EGPA_Marketing Authorisation

PDF 504KB

Intimation-Tagrisso_Additional Indication

PDF 353KB

Press Release_Financial Results Q4 2024-25

PDF 1,246KB

Tax Intimation-AY_2014_15_Final Order

PDF 513KB

Change in Managing Director

PDF 466KB

Imfinzi - Additional Indication

PDF 216KB

Determination of Materiality – Details of KMP

PDF 264KB

Response to SE – Intimation – Launch of Soliris

PDF 494KB

Outcome of Board Meeting – 14 Aug 2025

PDF 2,760KB

Intimation – NPPA Show Cause Notice

PDF 296KB

Intimation – Lokelma Launch

PDF 209KB

Intimation – Sun Pharma Second Brand deal

PDF 305KB

Intimation – Determination of Materiality

PDF 282KB

Intimation for Record Date

PDF 227KB

Intimation - Imfinzi DUO E

PDF 240KB

Newspaper Publication - AGM

PDF 2,750KB

Press Release Q1 2025-26

PDF 1,049KB

ESG Rating - Crisil

PDF 397KB

Intimation – Resignation of Mr. Pankaj Jain

PDF 702KB

Intimation – Resignation of Company Secretary

PDF 364KB

Intimation – Resignation of Dr. Ajay

PDF 272KB

Intimation – MA for Datverzo

PDF 230KB

ESG Rating - NSE Sustainability

PDF 272KB

Intimation - ESG Rating

PDF 267KB

Response to SE - Rumour verification

PDF 277KB

Proceedings of AGM -2025

PDF 246KB

Intimation - Surrender of manufacturing license

PDF 210KB

Intimation – Enhertu Additional Indication

PDF 217KB

Press release Q2 2025-26

PDF 560KB

Tax Intimation_AY 2020 – 21 CIT Order

PDF 258KB

Appointment of Amita Bhave as Director - Regulatory Affairs

PDF 241KB

Intimation Launch of Synagis

PDF 295KB

Press Release Q1 2024-25

PDF 454KB

Record Date

PDF 268KB

Intimation on AY 2020-21

PDF 278KB

Appointment of Vinay Sharma as Business Head

PDF 244KB

Intimation AZ & Symbicort deal

PDF 595KB

Change in role of Mina Patel & Appointment of Srikanth B.S. as Factory Head

PDF 278KB

Investor Meeting announcement

PDF 279KB

Intimation Constitution of Risk Management Committee

PDF 263KB

Intimation for CIT Order AY 2018-19

PDF 278KB

Appointment of Ayush Agarwal as BBU Director

PDF 283KB

Intimation MA Andexanet

PDF 267KB

Intimation MA Enhertu

PDF 261KB

Appointment of Shikha Mirchandani as Director - Commercial Excellence

PDF 242KB

Dividend declaration for FY 2023-24

PDF 264KB

Appointment of Ms. Bhavana Agrawal and Resignation of Ms. Sarah Wang

PDF 528KB

Press Release - Financial Results March 31, 2024

PDF 529KB

Resignation of Mr. Ankush Nandra

PDF 293KB

Intimation Withdrawal of indication – Olaparib

PDF 244KB

Intimation for Factory Update

PDF 276KB

Intimation for ITAT Order AY 2016-17

PDF 279KB

Intimation Additional indication Imfinzi

PDF 272KB

Intimation AY 2021-22 Final Assessment_Order

PDF 278KB

Intimation Dr. Anil Kukreja resignation

PDF 435KB

Intimation Launch of Imjudo

PDF 261KB

Intimation for Appointment of Ms. Monica, Cessation of Mr. Seshadri and Appointment of Chairperson

PDF 310KB

Press Release Q2 2024-25

PDF 2,399KB

Intimation - Appointment of Mr. Jesus Javier Diaz Ropero Esteso

PDF 2,370KB

Intimation for Launch Breztri

PDF 267KB

Additional Indication Lynparza

PDF 245KB

Appointment of Amita Bhave

PDF 241KB

Intimation AY 2017-18 and 2018-19_ITAT orde

PDF 274KB

Intimation - AY 2022-23 TPO order

PDF 303KB

Appointment of Ms. Sylvia Varela

PDF 270KB

Appointment of Ms. Hooi Bien

PDF 272KB

Appointment of Mr. Venkat Natarajan

PDF 274KB

Intimation MA Breztri

PDF 251KB

Intimation Launch Enhertu

PDF 249KB

Intimation MA Lynparza

PDF 258KB

Disclosure Factory related update

PDF 272KB

Intimation tax matters AY 2021-22 Draft order

PDF 308KB

Retirement and Appointment of CFO

PDF 293KB

Appointment Praveen Akkinepally

PDF 265KB

Change in Role Atul Tandon

PDF 273KB

Intimation Tax emails

PDF 379KB

Intimation additional indication Durvalumab (Imfinzi)

PDF 264KB

Intimation MA Synagis

PDF 270KB

Intimation additional indication Dapagliflozin Tablets 10mg

PDF 276KB

Intimation indication Trastuzumab deruxtecan (Enhertu)

PDF 263KB

Half yearly Related Party Transactions March 31, 2023

PDF 317KB

Intimation Pending Litigations

PDF 342KB

Intimation Launch Koselugo

PDF 257KB

Intimation indication Tremelimumab (Imjudo)

PDF 255KB

Intimation Retirement and Appointment of CFO

PDF 292KB

Intimation under Reg.30 of SEBI Listing Regulations_Press Release_17 Apr 2018

PDF 206KB

Intimation under Reg.30 of SEBI Listing Regulations Dist Agreement

PDF 231KB

Intimation under Reg.30 of SEBI Listing Regulations_Imfinzi_21 June 2018

PDF 337KB

Intimation under Reg.30 of SEBI Listing Regulations_Press Release_Tagrisso_9 Aug 2018

PDF 389KB

Intimation under Reg.30 of SEBI 28 July 2017

PDF 748KB

Intimation under Reg.30 of SEBI June 2017

PDF 236KB

Outcome of Board Meeting 29 June 2017

PDF 195KB

Intimation under Reg. 30_Qtern_25.09.2019

PDF 136KB

Intimation under Reg.30 of SEBI Listing Regulations MA Xigduo 16 October 2017

PDF 748KB

Outcome of Board Meeting 2 Feb 2017

PDF 300KB

Intimation under Reg.30 of SEBI 21 July 2017

PDF 230KB

Intimation under Reg.30 of SEBI Listing Regulations Xigduo 14 December 2017

PDF 224KB

Intimation under Reg.30 of SEBI Listing May 2017

PDF 253KB

Disclosure under Reg. 30 of SEBI Listing Regulations - January 2017

PDF 253KB

Intimation under Reg. 30 of SEBI Listing Regulations - December 2016

PDF 218KB

Intimation under Reg. 30 of SEBI Listing Regulations

PDF 509KB

AstraZeneca_Press release 23 March 2016

PDF 520KB

Change in the Compliance officer

PDF 231KB

Outcome of Board meeting 2 Dec 2016 - Change in Directors

PDF 323KB

Closure of Share Transfer books and Register of Members

PDF 228KB